Investment Rating - The report assigns a "Buy" rating for the company, Wallrun Technology (壁仞科技) [2][7]. Core Insights - Wallrun Technology is a leading domestic AI chip company focusing on GPGPU architecture and intelligent computing solutions, with a strong emphasis on proprietary technology and a diverse team background [6][15]. - The company has achieved significant revenue growth projections, with expected revenues of RMB 9.5 billion, RMB 20.2 billion, and RMB 39.5 billion for the years 2025 to 2027, respectively [7]. - The report highlights the company's innovative product offerings, including the BR106 and BR166 chips, which are designed for large-scale AI training and inference applications [25][28]. Financial Data and Profit Forecast - Revenue projections for Wallrun Technology are as follows: RMB 62 million in 2023, RMB 337 million in 2024, RMB 945 million in 2025, RMB 2,021 million in 2026, and RMB 3,951 million in 2027, with year-on-year growth rates of 12,330.86%, 442.97%, 180.61%, 113.83%, and 95.51% respectively [5]. - Adjusted net profit forecasts indicate losses of RMB 1,051 million in 2023, RMB 767 million in 2024, RMB 827 million in 2025, and a reduced loss of RMB 632 million in 2026, with a projected profit of RMB 74 million in 2027 [5][7]. - The company's gross margin is expected to fluctuate, with rates of 76.4% in 2023, 53.2% in 2024, and 31.9% in the first half of 2025, primarily due to changes in product sales mix [6][35]. Technology and Product Development - Wallrun Technology focuses on GPGPU architecture and has developed a comprehensive hardware and software ecosystem, including the BIRENSUPA software platform, which supports major AI frameworks [20][31]. - The company is pioneering advanced technologies such as Chiplet architecture and optical interconnects, enhancing the performance and scalability of its AI computing systems [50][53]. - The BR20X chip is expected to be commercialized in 2026, featuring improved performance and support for various data formats, further solidifying the company's market position [29][30]. Market Position and Ecosystem - Wallrun Technology has established strong partnerships with major telecommunications operators and is expanding its customer base, with a projected revenue contribution from its top five customers decreasing over time [6][38]. - The report emphasizes the growing domestic AI capital expenditure (Capex) market, which is expected to accommodate multiple AI chip companies, indicating a favorable environment for Wallrun Technology's growth [8][7]. - The company has successfully implemented a domestic supply chain strategy, ensuring production and research continuity despite external challenges [54].

Core Viewpoint - The Hong Kong IPO market has become increasingly active in 2026, with insurance capital accelerating its investments in this market, highlighting a trend towards global asset allocation and the pursuit of undervalued quality assets [1][2][6]. Group 1: Insurance Capital Participation - Since January 2026, insurance capital has participated in cornerstone subscriptions for 10 Hong Kong IPOs, with a total subscription amount of HKD 1.558 billion [1][6]. - In 2025, insurance capital participated in cornerstone subscriptions for 12 Hong Kong IPOs, amounting to HKD 2.620 billion [1][6]. - Key cornerstone investors in recent IPOs include Ping An Life and Taikang Life, with significant allocations in companies like Muyuan Foods and Dongpeng Beverage [2][6]. Group 2: Market Dynamics and Investment Preferences - The low interest rate environment has made the Hong Kong market a primary avenue for insurance capital's global asset allocation, with many undervalued quality assets available [2][6]. - Companies listed in both A-shares and H-shares often have H-shares priced at a discount compared to A-shares, making them attractive for insurance capital seeking better valuations and higher dividend yields [2][6]. - Insurance capital is increasingly focusing on "hard technology" and new consumption sectors, with some projects experiencing competitive bidding [3][7]. Group 3: Performance and Tax Advantages - The Hong Kong capital market regained the top position globally for IPO fundraising in 2025, raising USD 37.4 billion, surpassing the total of the previous three years [3][7]. - Newly listed stocks have performed well, with an average first-day increase of 23.8% and a cumulative first-month increase of 30.7%, particularly in the biotech and healthcare sectors [3][7]. - Insurance companies benefit from tax advantages in Hong Kong, as they can avoid corporate income tax on dividends from H-shares held for over 12 months, enhancing their net returns compared to individual investors [8].

Core Viewpoint - The Hong Kong stock market saw significant gains in chip stocks, with notable increases in share prices for several companies on February 12, indicating a positive trend in the semiconductor sector [1]. Group 1: Stock Performance - Tianshu Zhixin (09903) experienced a rise of 19.07%, reaching a latest price of 229.800 with a total market capitalization of 584.42 billion [2]. - Zhaoyi Innovation (03986) increased by 18.45%, with a latest price of 350.600 and a market cap of 2458.07 billion, marking a year-to-date increase of 116.42% [2]. - Biran Technology (06082) saw an 8.39% rise, with a latest price of 36.420 and a market cap of 888.23 billion, reflecting an 85.82% increase year-to-date [2]. - Lanke Technology (06809) rose by 7.18%, with a latest price of 185.100 and a market cap of 2244 billion, showing a year-to-date increase of 73.17% [2]. - Tianyu Semiconductor (02658) increased by 6.19%, with a latest price of 52.500 and a market cap of 206.47 billion, reflecting a year-to-date increase of 9.38% [2].

Core Viewpoint - Wallen Technology (06082) has seen a significant stock increase, rising nearly 12% in the afternoon session, with a current price of 36.64 HKD and a trading volume of 277 million HKD, following the release of the MOSS-TTS Family by the MOSS team and the successful deployment of the MOSS-TTS model by Wallen Technology as the first domestic computing power vendor to adapt this model [1] Group 1 - Wallen Technology's flagship product, the Bili 166M, has successfully completed high-performance inference deployment of the MOSS-TTS model [1] - The MOSS-TTS Family was officially released and open-sourced on February 10 by the MOSS team, incubated by Shanghai Chuangzhi Academy [1] - Goldman Sachs has initiated coverage on Wallen Technology with a "Buy" rating and a target price of 54 HKD, citing growth in domestic cloud vendor capital expenditure and the rise of the local AI ecosystem [1] Group 2 - Wallen Technology's AI training/inference GPU business is projected to achieve a compound annual growth rate of 101% from 2025 to 2030, positioning the company as a key player in the domestic AI computing power market [1] - The report emphasizes the opportunities presented by the localization of AI computing power as a significant factor for Wallen Technology's growth [1]

Core Viewpoint - Wallen Technology (06082) has seen a significant stock increase, rising nearly 12% in the afternoon session, with a current price of 36.64 HKD and a trading volume of 277 million HKD. The company has successfully deployed the MOSS-TTS model, becoming the first domestic computing power vendor to adapt this model, which is expected to drive future growth in AI-related revenue [1][1][1]. Company Summary - Wallen Technology's flagship product, the Bili 166M, has completed the high-performance inference deployment of the MOSS-TTS model, marking a significant milestone for the company [1][1]. - The company has been recognized as the first domestic computing power vendor to adapt the MOSS-TTS model, highlighting its competitive edge in the AI sector [1][1]. Industry Summary - Goldman Sachs has initiated coverage on Wallen Technology with a "Buy" rating and a target price of 54 HKD, citing the growth in capital expenditures from domestic cloud vendors and the rise of the local AI ecosystem as key drivers for the company's future performance [1][1]. - The report projects that Wallen Technology's AI training/inference GPU business revenue will achieve a compound annual growth rate of 101% from 2025 to 2030, positioning the company as a core player in the domestic AI computing power market [1][1].

Group 1 - The core point of the article is that Biran Technology has announced the successful deployment of the MOSS-TTS model, becoming the first domestic computing power vendor to adapt this model [1] - The MOSS-TTS Family was officially released and open-sourced by the MOSS team, which was incubated by Shanghai Chuangzhi Academy [1] - Biran Technology's flagship product, Bili 166M, has completed high-performance inference deployment of the MOSS-TTS model [1]

Summary of Biren (6082.HK) Conference Call Company Overview - **Company**: Biren (6082.HK) - **Industry**: AI and GPU technology - **Market Cap**: HK$82.1 billion / $10.5 billion - **Enterprise Value**: HK$73.5 billion / $9.4 billion - **Current Price**: HK$33.66 - **Target Price**: HK$54.00 - **Upside Potential**: 60.4% [1][6][41] Core Insights - **Growth Projections**: Biren's AI training/inferencing GPU business is expected to achieve a **101% CAGR** from 2025 to 2030, driven by: 1. Increased **China Cloud Capex** spending, indicating a ramp-up in AI infrastructure following the launch of local foundation models in late 2024. 2. Market share gains in China due to a competitive price-to-performance ratio and government support for local AI chips. 3. Migration to AI chips with higher computing power, particularly with the launch of the **BR166 modules** in August 2025. 4. A full-stack solution that accelerates AI deployment for clients. 5. Expansion of advanced node capacity in China to support local AI chip growth [1][2][31]. - **Revenue and Shipment Growth**: - Expected **AI chip shipments** to grow at **96% CAGR** from 2025 to 2030, reaching **0.9 million units** by 2030, up from **0.03 million units** in 2025 [2][31]. - Revenue growth is projected to reach **Rmb 5,588.8 million** by 2027, with a **161% YoY** increase in 2027-28 [2][15]. - **Valuation Metrics**: - Target price based on a **2030E discounted EV/EBITDA** methodology, with a target multiple of **46.6x** derived from peer comparisons [2][41]. - Implies a **20x 2027E P/S** ratio, compared to peers like Verisilicon (16.7x), NVIDIA (8.2x), and AMD (5.7x) [2][41]. Key Risks - Potential risks include: - Lower-than-expected demand for AI chips in the Chinese market. - Increased competition in the market. - Wafer supply restrictions affecting GPU board shipments [17]. Financial Highlights - **Revenue Forecast**: - 2025: Rmb 945.4 million - 2026: Rmb 1,919.0 million - 2027: Rmb 5,588.8 million [15][36]. - **EBITDA Forecast**: - Expected to remain negative until 2028, with a projected EBITDA of **Rmb 3 billion** by 2030 [34][36]. - **Net Income**: - Expected to turn positive in 2028, reaching **Rmb 3 billion** by 2030 [34][36]. Product Development - Upcoming products include: - **BR106**: Launched in 2023 for AI training/inferencing. - **BR166**: Expected in 2025, integrating two BR106 dies for enhanced performance. - **BR20X** and **BR30X**: Planned for 2026 and 2028, respectively, focusing on improved computing power and efficiency [32][31]. Conclusion - Biren is positioned for significant growth in the AI GPU market, supported by strong demand, government backing, and innovative product development. The investment recommendation is a **Buy** with a target price of **HK$54**, reflecting a robust upside potential based on projected revenue and market dynamics [1][41].

Core Viewpoint - The Hong Kong IPO market has seen a surge in activity since the beginning of 2026, with insurance capital accelerating its investments in this market, indicating a strategic shift towards global asset allocation and a preference for undervalued quality assets [1][2]. Group 1: Insurance Capital Participation - Since January 2026, insurance capital has participated in cornerstone subscriptions for 10 Hong Kong IPOs, with a total subscription amount of HKD 1.558 billion, compared to HKD 2.620 billion for 12 IPOs in 2025 [1]. - Major cornerstone investors in recent IPOs include Ping An Life and Taikang Life, with Ping An Life acquiring 6 million shares of Muyuan Foods, representing 2.2% of the base issuance, and Taikang Life acquiring 943,100 shares of Dongpeng Beverage, representing 2.31% of the H-share issuance [3][4]. Group 2: Market Dynamics and Preferences - The current low-interest-rate environment makes the Hong Kong market an attractive avenue for insurance capital seeking global asset diversification, especially given the lower valuations and higher dividend yields of H-shares compared to A-shares [2]. - Insurance capital is increasingly focusing on "hard technology" and new consumption sectors, aligning with national strategic priorities, and has shown a tendency to engage in competitive bidding for select IPO projects [3]. Group 3: Long-term Investment Logic - In 2025, Hong Kong's capital market regained its position as the global leader in IPO fundraising, with a total of USD 37.4 billion raised, marking a new high since 2021 and surpassing the total of the previous three years [5]. - The average first-day increase for new stocks was 23.8%, with a cumulative first-month increase of 30.7%, particularly strong in the biotech and healthcare sectors, making the IPO market appealing for insurance capital seeking stable returns [5]. - Tax advantages for insurance companies, such as exemptions on dividend income from H-shares held for over 12 months, enhance the attractiveness of investing in Hong Kong stocks compared to individual investors and mainland public funds [5].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 上海壁仞科技股份有限公司 呈交日期: 2026年2月4日 I. 法定/註冊股本變動 FF301 上海壁仞科技股份有限公司（「本公司」）的普通股（H股）於2026年1月2日（「上市日」）在香港聯合交易所有限公司主板上市，上述「上月底結存」的結存是指本公司於上市日的相關註冊股本 結存。 | 2. 股份分類 | 普通股 | 股份類別 | 其他類別 (請註明) | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | N/A | 說明 | 內資股 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,238,013,076 RMB | | 0.02 | RMB | | 24,760,261.52 | | 增加 / 減少 (-) ...

Group 1 - Hong Kong chip stocks opened lower, with Shanghai Fudan (01385.HK) dropping over 4% [1] - Other stocks such as Hua Hong Semiconductor (01347.HK), Zhaoyi Innovation (03986.HK), SMIC (00981.HK), ZTE Corporation (00763.HK), and Biren Technology (06082.HK) also declined [1] - In contrast, InnoCare Pharma (02577.HK) saw a strong performance, rising over 6% [1]